Our studies showed that knockdown of SRSF10 could enhance apoptosis and inhibit the viability, proliferation, and clonogenic formation in lung cancer cells, while CK1 inhibitor SR3029 further potentiated the effect of silencing SRSF10 on lung cancer cells. The gene discussed is SRSF10; the disease is lung carcinoma.